Fatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation [9]

Haematologica

Volumn 86, Issue 9, 2001, Pages 1002-1003

  Kanda, Y ^a   Matsumura, T ^a   Maki, K ^a   Matsuyama, T ^a   Chiba, S ^a   Hirai, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Carboplatin; Cardiac toxicity; Conditioning regimen; Cyclophosphamide; Cytarabine

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE;

ADULT; B CELL LYMPHOMA; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DISEASE COURSE; DOSE RESPONSE; DRUG FATALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; FATAL OUTCOME; FEMALE; HEART DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAXIMUM TOLERATED DOSE; MIDDLE AGED; TRANSPLANTATION CONDITIONING;

EID: 0034791199     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. High-dose cyclophosphamide therapy for malignant diseases. Toxicity, tumor response, and the effects of stored autologous marrow
2. Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation
3. Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy
4. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
5. Comparison among three preconditioning regimens for allogeneic bone marrow transplantation in hematological malignancies